Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024)

Historic Acquisitions for Ani Pharmaceuticals (ANIP) over the last 3 years, with Q4 2024 value amounting to $8.2 million.

  • Ani Pharmaceuticals' Acquisitions changed N/A to $8.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.2 million, marking a year-over-year change of. This contributed to the annual value of $401.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Acquisitions of $8.2 million as of Q4 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Acquisitions peaked at $84.5 million during Q4 2021, and registered a low of $8.2 million during Q4 2024.